Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.

Latest updates to the Prevent Early Onset AD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no other visible changes to the page content.SummaryDifference0.0%

- Check21 days agoChange DetectedThese changes are minor editorial updates related to the PubMed publication text and the revision version numbers, and do not affect the core study details or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study status is updated to Active, not recruiting, and an arm is noted as completed and closed with subcutaneous dosing every 4 weeks. Last update timestamps show 2025-11 for both posted and estimated updates, and older recruitment contact details have been removed.SummaryDifference5%

- Check43 days agoChange DetectedThe screenshots show no substantive updates to study details, eligibility criteria, or locations; any differences appear to be minor formatting or layout changes rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check79 days agoChange DetectedUpdated page version to v3.1.0 and added an identifier/contact (844-DIANEXR with phone 342-6397); removed the previous revision v3.0.2.SummaryDifference0.0%

Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.